Clinical phenotypes of coronary artery disease patients with intermediate coronary artery stenosis

I n t r o d u c t i o n .  Patients with stable coronary artery disease (CAD) and intermediate coronary artery stenosis are of great interest because, despite the absence of obstructive coronary artery lesion, the risk of cardiovascular complications is very high and is conditioned by a number of concomitant factors.

A i m .  Study of cardiovascular risk factors and assessment of clinical and angiographic picture in stable CAD patients with intermediate coronary artery stenosis of various clinical phenotypes.

M a t e r i a l s   a n d   m e t h o d s .  236 stable angina pectoris class I–III patients (190 men, 46 women, age 49–59 years) with intermediate (40–70%) coronary artery stenosis were examined. All patients underwent general clinical examination, ultrasound of the heart and coronary angiography. Based on the cardio-ankle vascular index (CAVI) values, the chronological age/biological age coefficient was determined. The study design is a comparative non-randomized descriptive study of four parallel groups.

R e s u l t s .  The prevailing phenotypes in CAD patients with intermediate (40–70%) coronary artery stenosis in a random sample turned out to be those with: CAD without a previous myocardial infarction (MI); CAD with MI > 6 months ago; CAD with metabolically unhealthy obesity (MUO) phenotype without diabetes mellitus (DM) and, finally, CAD with type 2 DM. In CAD patients with MUO and type 2 DM, the frequency of previous MI did not significantly differ. In addition, patients with CAD and MUO, who had previously had MI, differed in the earliest age of its onset. Despite the 100% presence of arterial hypertension (AH) in different phenotypes groups, CAD and type 2 DM patients had the highest values of the left ventricular mass index. They also had the most frequently recorded multivessel lesion during coronary angiography. Despite the ongoing outpatient year-long treatment, the values of lipid and inflammatory parameters (low-density lipoprotein cholesterol (LDL-C), triglycerides, C-reactive protein) were high, so, only in few patients the target values of LDL-C were reached; besides a large number of patients with insufficient blood pressure control were revealed. In more than half of the surveyed, the biological age prevailed over the chronological age.

C o n c l u s i o n .  Stable angina patients with intermediate coronary artery stenosis represent a rather serious group in terms of prognosis. Despite the absence of vascular obstructive lesions, the risk of cardiovascular complications is conditioned by almost 100% presence of hypertension, high body mass index values, a significant frequency of obesity, dyslipidemia, carbohydrate metabolism disorders, and high biological age.

1. Sanchis-Gomar F., Perez-Quilis C., Leischik R., Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann. Transl. Med. 2016;4(13):256. DOI: 10.21037/atm.2016.06.33.

2. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. DOI: 10.1371/journal.pmed.0030442.

3. Tavella R., Beltrame J.F. Angina pectoris: how has the clinical presentation evolved? Is it still the same today as it was several years ago? e-J. Card. Pract. 2017;15(1).

4. Heberden W. Some account of a disorder of the breast. Medical Transactions of the Royal College of Physicians of London. 1772;2:59.

5. Parry C.H. An inquiry into the Symptoms and Causes of Syncope Anginosa, Commonly Called Angina Pectoris. Edinburgh, London: Bryce, Murray and Callow. 1799.

6. Gray C.R., Hoffman H.A., Hammond W.S., Miller K.L., Oseasohn R.O. Correlation of arteriographic and pathologic findings in the coronary arteries in man. Circulation. 1962;26:494–499.

7. Stefano G.T., Bezerra H.G., Attizzani G. et al. Utilization of frequency domain optical coherence tomography and fractional flow reserve to assess intermediate coronary artery stenoses: conciliating anatomic and physiologic information. Int. J. Cardiovasc. Imaging. 2011;27(2):299–308. DOI: 10.1007/s10554-011-9847-9.

8. Reeh J., Therming C.B., Heitmann M. et al. Prediction of obstructive coronary artery disease and prognosis in patients with suspected stable angina. Eur. Heart J. 2019;40(18):1426–1435. DOI: 10.1093/eurheartj/ehy806.

9. Knuuti J., Wijns W., Saraste A. et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur. Heart J. 2020;41(3):407–477. DOI: 10.1093/eurheartj/ehz425.

10. D’Andrea A., Severino S., Mita C. et al. Clinical outcome in patients with intermediate stenosis of left anterior descending coronary artery after deferral of revascularization on the basis of noninvasive coronary flow reserve measurement. Echocardiography. 2009;26(4):357–487. DOI: 10.1111/j.1540-8175.2008.00807.x.

11. Einarson T.R., Acs A., Ludwig C., Panton U.H. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc. Diabetol. 2018;17(1):83. DOI: 10.1186/s12933-018-0728-6.

12. Rahman H., Corcoran D., Aetesam-Ur-Rahman M. et al. Diagnosis of patients with angina and nonobstructive coronary disease in the catheter laboratory. Heart. 2019;105:1536–1542. DOI: 10.1136/heartjnl-2019-315042.

13. Wright A.K., Kontopantelis E., Emsley R. et al. Cardiovascular risk and risk factor management in type 2 diabetes mellitus. Circulation. 2019;139(24):2742–2753. DOI: 10.1161/CIRCULATIONAHA.118.039100.

14. Nicholls S.J., Tuzcu E.M., Kalidindi S. et al. Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials. J. Am. Coll. Cardiol. 2008;52(4):255–262.

15. Lavie C.J., Milani R.V., Ventura H.O. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J. Am. Coll. Cardiol. 2009;53(21):1925–1932. DOI: 10.1016/j.jacc.2008.12.068.

16. Galassi A., Reynolds K., He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am. J. Med. 2006;119(10):812–819. DOI: 10.1016/j.amjmed.2006.02.031.

17. Gami A.S., Witt B.J., Howard D.E. et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J. Am. Coll. Cardiol. 2007;49(4):403–414.

18. Yakhontov D.A., Ostanina Ju.O. Early vascular aging syndrome in young and middle age patients with hypertension and coronary artery disease. Medical Alphabet. 2018;1(3):33–36. (In Russ.)

19. Nilsson P.M., Yakhontov D.A., Ostanina Yu.O. Early vascular aging. Nowadays status of the problem (review). Siberian Scientific Medical Journal. 2016;5(36):6–13. (In Russ.)

20. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Atheroscleroz. 2020;16(3):61–81. DOI: 10.15372/ATER20200308. (In Russ.)

21. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020;25(3):3786. DOI: 10.15829/1560-4071-2020-3-3786. (In Russ.)

22. 2020 Clinical practice guidelines for stable coronary artery disease. Russian Journal of Cardiology. 2020;25(11):4076. DOI: 10.15829/1560-4071-2020-4076. (In Russ.)

23. Alieva A.S., Boyarinova M.A., Baranova E.I. et al. Association of vascular age with metabolic health in obese patients. Russian National Congress of Cardiologists: collection of theses. Yekaterinburg, 2019. P. 813. (In Russ.)